WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke MICRONOID wurde als Wortmarke am 27.07.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1555335 |
| Länder | 
|
| Basismarke |
Nr. 88777356,
29. Januar 2020
|
| Anmeldedatum | 27. Juli 2020 |
| Ablaufdatum | 27. Juli 2030 |
Markeninhaber
170 Park Avenue
Florham Park NJ 07932
US
Florham Park NJ 07932
US
Markenvertreter
1650 Market Street,
Suite 2800
US
Waren und Dienstleistungen
01
Cells and biological tissue, namely, blood, stem cells,
umbilical cords, umbilical cord blood, placental tissue for
use in scientific, laboratory and medical research;
bioengineered cells for use in scientific, laboratory and
medical research; human allograft tissue made from human
umbilical cords and human placentas for use in scientific,
laboratory and medical research; human amniotic membrane and
human chorionic membrane for use in scientific, laboratory
and medical research; human collagen and extracellular
matrix compositions for use in scientific, laboratory and
medical research; biological preparations for use in
scientific, laboratory and medical research; biological
products for use in scientific, laboratory and medical
research, namely, placental-derived natural killer cells
05
Cells and biological preparations intended for medical and
clinical use, namely, blood, stem cells, umbilical cord
cells, umbilical cord blood, and placental allograft tissue;
bioengineered cells for use in immunotherapies for cancer
and other diseases; human allograft tissue made from human
umbilical cords and human placentas intended for subsequent
implantation; human amniotic membrane and human chorionic
membrane intended for subsequent implantation; human
collagen compositions and extracellular matrix compositions
intended for subsequent implantation; biological
preparations for medical use, namely, for the treatment of
cancer and other diseases, namely, auto-immune diseases,
inflammatory diseases, crohn's disease and multiple myeloma;
biological products for medical use, namely,
placental-derived natural killer cells, and
placental-derived cytotoxic T cells with a chimeric antigen
receptor (CAR) specific for a cancer or other
disease-associated antigen; cells and biological tissue
intended for hair restoration, namely, cells and biological
preparations derived from blood, stem cells, umbilical
cords, umbilical cord blood, and placental tissue;
biological tissue intended for use as a wound covering;
wound dressings; burn dressings; surgical dressings;
pharmaceutical preparations for wounds; biological products
for medical use, namely, placental-derived cytotoxic T cells
with a chimeric antigen receptor (CAR) specific for a cancer
or other disease-associated antigen
42
Research, development and testing services for others in the
fields of genomics, biotechnology and pharmaceuticals; stem
cell research services; research, development and testing
services in the fields of genomics, biotechnology and
pharmaceuticals, namely, collection, testing, processing,
preservation, storage and retrieval of cells and biological
tissue, namely, blood, stem cells, umbilical cords,
umbilical cord blood, and placental tissue; providing
information in the field of medical research relating to
banking stem cells and cord blood banking via a website;
medical research to find methods to restore the structure
and function of damaged or diseased tissues and organs,
including wound care, reconstructive medicine, whole organ
and tissue regeneration and renewal; medical research
regarding emergent cell therapies; medical research
regarding allogeneic immunotherapy; providing on-line
information, news and commentary in the field of medical
research relating to the foregoing
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 01. Juni 2022 | 2022/23 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 23. September 2021 | 2021/38 Gaz | JP | Ablehnung |
| 03. September 2021 | 2021/37 Gaz | KR | Ablehnung |
| 15. April 2021 | 2021/16 Gaz | GB | Ablehnung |
| 04. März 2021 | 2021/15 Gaz | EM | Ablehnung |
| 18. Februar 2021 | 2021/15 Gaz | CN | Ablehnung |
| 27. Juli 2020 | 2020/40 Gaz | US | Eintragung |
ID: 141555335